Assessment of pregestational insulin resistance as a risk factor of preeclampsia
Artículo
Publication date
2014Metadata
Show full item record
Cómo citar
Valdés Rubio, Enrique
Cómo citar
Assessment of pregestational insulin resistance as a risk factor of preeclampsia
Abstract
Aim: To assess the impact that pregestational insulin resistance
(PIR) has as a risk factor for preeclampsia (PE). Methods:
Nested case-control study that included patients with
PIR and a control group that was randomly selected from
pregnancies admitted to the Fetal Medicine Unit between
January 2005 and May 2011. Clinical and hemodynamic variables
were analyzed by a multiple logistic regression analysis.
Results: Of the 13,124 patients admitted during the study
period, 119 had a diagnosis of PIR (0.9%). Patients with PIR
were older and had a higher body mass index (BMI). PIR was
also related to a significantly higher frequency of chronic hypertension
(CrHT; 10.1 vs. 2.2%, p < 0.05) and hypothyroidism
(5.0 vs. 1.6%, p < 0.05) than in the control group. Moreover,
women with PIR were more likely to develop PE (8.4 vs.
4.2%, p < 0.05) and gestational diabetes mellitus (9.2 vs.
2.9%) than the control group. Multivariate analysis showed
that maternal age, CrHT and altered uterine artery Doppler
sonography during the first and second trimesters were
good predictors of PE and that PIR was not. Conclusion: Although PIR correlates with PE, conditions related to the latter
(CrHT, higher maternal age and increased BMI) may be predominant
as risk factors for PE.
General note
Artículo de publicación ISI
Patrocinador
This research was funded by the Fondo Nacional de Ciencia y Tecnología, grant No. 1130668
Quote Item
Gynecol Obstet Invest 2014;77:111–116
Collections